UnitedHealth Group reported strong Q2 results with beats on revenue and EPS, and raised its full-year 2026 guidance. The company maintained a stable medical loss ratio of 86.7%, and analysts have upgraded EPS estimates with no downgrades, reflecting confidence in its long-term growth. Despite recent underperformance against the S&P 500, UnitedHealth's valuation remains attractive with a 6.9% free cash flow yield. Technically, the stock shows a bullish primary trend but faces key support levels around mid-$350s, with potential downside if it drops below $370.
Following UnitedHealth's upbeat 2026 outlook, its stock price on Pluang stands at USD 382.00 as of Sep 15, 2026 16:41 WIB, showing a slight 0.40% decline over the day. The company holds a market capitalization of $340.27 billion and offers a dividend yield of 2.45%, reflecting its strong position in the health sector despite recent price fluctuations.
SCHD and JEPI ETFs serve different income strategies: SCHD focuses on steady, growing dividends from strong company cash flows, ideal for long-term compounding and taxable accounts. JEPI provides higher monthly income by selling options, generating f...
The Schwab U.S. Dividend Equity ETF (SCHD) underwent its annual March reconstitution, replacing 22 stocks with 25 new ones, notably increasing holdings in semiconductors and energy sectors. This reshuffle altered the dividend profile and sector expos...
